日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group

儿童肿瘤协作组报告:RANKL抗体地诺单抗治疗复发/难治性骨肉瘤两组患者的II期临床试验

Janeway, Katherine A; Chou, Alexander J; Buxton, Allen; Reid, Joel; Isakoff, Michael S; Kopp, Lisa; Hingorani, Pooja; Lee, Jill L; Doski, John; Daldrup-Link, Heike; Hall, Laura; Randall, R Lor; Reed, Damon R; Dubois, Steven G; Krailo, Mark; Grier, Holcombe; Gorlick, Richard

Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas

胶原蛋白破坏剂 attIL12 TIL 疗法通过双重信号激活和 CCKAR 减少促进肉瘤中深层 T 细胞浸润

Hu, Jiemiao; Singh, Harjeet; Jin, Yining; Zhang, Wendong; Wang, Jian; Xia, Xueqing; Somaiah, Neeta; Gorlick, Richard; Li, Shulin

Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group

儿童肿瘤协作组关于AEWS1031研究中局限性尤文氏肉瘤患者术前放疗的报告

Indelicato, Daniel J; Callan, Alexandra K; Ahmed, Safia K; Krailo, Mark; DelRocco, Natalie; Buxton, Allen B; Binitie, Odion T; Christ, Alexander B; Kessell, Sandy; Chuba, Paul J; Nadel, Helen R; Pawel, Bruce R; Gorlick, Richard; Reed, Damon R; DuBois, Steven G; Janeway, Katherine A; Leavey, Patrick; Mascarenhas, Leo; Laack, Nadia N

Scoping Review of Adult Emergency Department Discharge Interventions

成人急诊科出院干预措施的范围界定审查

Gorlick, Mary-Kate; Balasubramanian, Shriman; Han, Gregory; Hickner, Andy; Talukder, Pranita; Steel, Peter Ad; Jiang, Lynn

Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma

叶酸受体α嵌合抗原受体T细胞的临床前评估显示出对骨肉瘤的高效抗肿瘤活性

Michelle Choe,Danielle Kirkey,Isabel Lira,Grace Hawkins,Melia Blankenfeld,Sarah Menashe,Rhonda E Ries,Brianna Wrightson,Christina Root,Cyd N McKay,Jack H Peplinski,Raisa Glabman,Lara E Davis,Sanjay V Malhotra,Richard Gorlick,Elizabeth T Loggers,Soheil Meshinchi

Retraction: Rpb3 promotes hepatocellular carcinoma through its N-terminus

撤稿:Rpb3 通过其 N 端促进肝细胞癌的发生

Sampson, Valerie B; Vetter, Nancy S; Zhang, Wendong; Patil, Pratima U; Mason, Robert W; George, Erika; Gorlick, Richard; Kolb, Edward A; Fang, Zhe-Ping; Jiang, Bei-Ge; Zhang, Fa-Biao; Wang, Ai-Dong; Ji, Yi-Ming; Xu, Yong-Fu; Li, Ji-Cheng; Zhou, Wei-Ping; Zhou, Wei-Jie; Han, Hai-Xiong

Lessons learned from 20 years of preclinical testing in pediatric cancers

从20年的儿科癌症临床前试验中汲取的经验教训

Smith, Malcolm A; Houghton, Peter J; Lock, Richard B; Maris, John M; Gorlick, Richard; Kurmasheva, Raushan T; Li, Xiao-Nan; Teicher, Beverly A; Chuang, Jeffrey H; Dela Cruz, Filemon S; Dyer, Michael A; Kung, Andrew L; Lloyd, Michael W; Mossé, Yael P; Stearns, Timothy M; Stewart, Elizabeth A; Bult, Carol J; Erickson, Stephen W

Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

细胞膜锚定和肿瘤靶向的 IL-12 T 细胞疗法破坏异质性骨肉瘤异种移植模型中的癌症相关成纤维细胞并破坏细胞外基质

Jiemiao Hu, Alexander J Lazar, Davis Ingram, Wei-Lien Wang, Wendong Zhang, Zhiliang Jia, Dristhi Ragoonanan, Jian Wang, Xueqing Xia, Kris Mahadeo, Richard Gorlick, Shulin Li

Mapping the Single-Cell Differentiation Landscape of Osteosarcoma.

绘制骨肉瘤单细胞分化图谱

Truong Danh D, Weistuch Corey, Murgas Kevin A, Admane Prasad, King Bridgette L, Chauviere Lee Jes, Lamhamedi-Cherradi Salah-E, Swaminathan Jyothishmathi, Daw Najat C, Gordon Nancy, Gopalakrishnan Vidya, Gorlick Richard G, Somaiah Neeta, Deasy Joseph O, Mikos Antonios G, Tannenbaum Allen, Ludwig Joseph

Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma

靶向抑制 SCFSKP2 可产生抗肿瘤活性,从而提高骨肉瘤患者的生存率

Jichuan Wang #, Alexander Ferrena #, Ranxin Zhang #, Swapnil Singh, Valentina Viscarret, Waleed Al-Harden, Osama Aldahamsheh, Hasibagan Borjihan, Amit Singla, Simon Yaguare, Janet Tingling, Xiaolin Zi, Yungtai Lo, Richard Gorlick, Edward L Schwartz, Hongling Zhao, Rui Yang, David S Geller, Deyou Zhe